Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Patheon, a provider of drug development and manufacturing services, has signed agreements to commercialize two Oros technology controlled release products from its Cincinnati facility.
Subscribe to our email newsletter
According to Patheon, Oros is a specialized drug delivery technology used to achieve the controlled release of active drug substances. When a patient swallows an Oros tablet, water is drawn into a specially formulated portion of the tablet which swells, exerting pressure on the tablet drug layer. This gentle pressure forces the active drug out through laser-drilled holes in the tablet, allowing for a gradual release of the active drug substance.
The first product will launch in late 2009 and the second is planned to launch in the third quarter of 2010, the company said.
Terry Novak, chief commercial officer of Patheon, said: “This process is very unique and requires special equipment and expertise to successfully develop and commercialize Oros-based products. Having the development and commercial expertise available at our Cincinnati facility allows our customers to quickly and successfully launch Oros-based products and extend the life cycle of their products.”